|
EQS-News: SARTORIUS AG
/ Key word(s): Sustainability
Göttingen, Germany | March 31, 2025
First ISCC Plus certifications pave the way for renewable plastics at Sartorius
The life science group Sartorius has earned its first certificates from the International Sustainability and Carbon Certification (ISCC) for its production sites in Aubagne, France, and Stonehouse, UK. Further plants in Germany and Finland are to follow. The ISCC Plus certification allows Sartorius to transparently source renewable, certified raw materials for the production of plastic components, significantly reducing the proportion of fossil-based materials. At its certified sites, Sartorius produces Ambr® bioreactor vessels, Vivaflow® filters, and selected Flexsafe® bags for the manufacture of biopharmaceuticals. ISCC’s transparent accounting system allows for the integration of renewable and recycled feedstock - such as recycled plastic – into existing processes, with usage tracked and documented across the entire value chain. In the three product lines, ISCC Plus-certified materials now cut the share of fossil-based compounds by an average of 50 percent. ”By using renewable materials, we are actively reducing fossil raw materials in our products, offering sustainable alternatives that our customers can easily adopt,” says René Fáber, Head of the Bioprocess Division and Member of the Executive Board at Sartorius. “For years, our technologies have helped customers to replace energy-, water- and chemical-intensive manufacturing processes for biopharmaceuticals with more resource-efficient single-use options, thereby reducing their environmental footprint. The ISCC Plus certification reinforces our ongoing commitment to advancing more sustainable practices.” In addition to supporting its customers’ sustainability efforts, Sartorius aims to further reduce its own ecological footprint and pursues significant climate ambitions: By 2045, Sartorius intends to fully decarbonize its business activities, achieve net-zero CO2 emissions and thus become climate neutral. By 2030, 100 percent of the electricity purchased worldwide should come from renewable sources. More information about Sartorius’ sustainability ambitions at A profile of Sartorius Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions Division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and sustainably. The company, based in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide. Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2024, the company generated sales revenue of around 3.4 billion euros. Around 13,500 employees are working for customers around the globe. Visit our and follow Sartorius on . Contact Leona Malorny Head of External Communications 7 Additional features: File:
31.03.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | SARTORIUS AG |
| Otto-Brenner-Straße 20 | |
| 37079 Göttingen | |
| Germany | |
| Phone: | +49.(0)551-308.0 |
| Fax: | +49.(0)551-308.3289 |
| E-mail: | |
| Internet: | |
| ISIN: | DE0007165631, DE0007165607 |
| WKN: | 716563, 716560 |
| Indices: | DAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2108680 |
| End of News | EQS News Service |
|
|
2108680 31.03.2025 CET/CEST
